Irritable Bowel Syndrome with Diarrhoea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meets the above Western medicine diagnostic criteria; (2) Aged 18-65 years, of any gender; (3) IBS-SSS score =75 points; (4) No organic intestinal lesions; (5) Has not taken any anti-diarrheal drugs, analgesics, antibiotics, and/or probiotics or other drugs related to IBS-D treatment within one month before entering this study; (6) Not participating in any other clinical study at the same time; (7) Patient voluntarily cooperates with this study and signs the informed consent form. Those meeting all the above 7 criteria can be included in the study.
Exclusion criteria
Exclusion criteria: (1) Other digestive system diseases presenting with diarrhea; (2) Patients with severe primary diseases or systemic diseases affecting gastrointestinal motility; (3) Individuals who are unconscious, unable to express subjective feelings, or unable to cooperate with treatment; (4) Those with allergies, pregnant women, and breastfeeding women; (5) Individuals who cannot tolerate acupuncture, or have infection or ulcers at the treatment site; (6) Those unwilling to sign the informed consent form. Meeting any of the above criteria will result in exclusion from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Irritable Bowel Syndrome Symptom Severity Scale;IBS Weekly Bowel Habit Bristol Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| IBS defecation state questionnaire;Hamilton Anxiety Rating Scale; | — |
Countries
China
Contacts
Shanxi Province Acupuncture Hospital